Usefulness of Pharmacologic Conversion of Atrial Fibrillation During Dofetilide Loading Without the Need for Electrical Cardioversion to Predict Durable Response to Therapy-Reference-Cited by-同舟云学术

Usefulness of Pharmacologic Conversion of Atrial Fibrillation During Dofetilide Loading Without the Need for Electrical Cardioversion to Predict Durable Response to Therapy

Published:2014-02 Issue:3 Volume:113 Page:475-479
ISSN:0002-9149
Container-title:The American Journal of Cardiology
language:en
Short-container-title:The American Journal of Cardiology

Author:

Malhotra Rohit,Bilchick Kenneth C.,DiMarco John P.

Funder

National Institutes of Health

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference19 articles.

1. Efficacy and safety of oral dofetilide in converting to and maintaining sinus rhythm in patients with chronic atrial fibrillation or atrial flutter: the Symptomatic Atrial Fibrillation Investigative Research on Dofetilide (SAFIRE-D) study;Singh;Circulation,2000

2. Dofetilide: a new class III antiarrhythmic agent;Roukoz;Expert Rev Cardiovasc Ther,2006

3. Dofetilide: a new antiarrhythmic agent approved for conversion and/or maintenance of atrial fibrillation/atrial flutter;Lenz;Drugs Today (Barc),2000

4. Comparison of intravenously administered dofetilide versus amiodarone in the acute termination of atrial fibrillation and flutter. A multicentre, randomized, double-blind, placebo-controlled study;Bianconi;Euro Heart J,2000

5. Efficacy and safety of dofetilide in patients with atrial fibrillation and atrial flutter;Banchs;J Interv Card Electrophysiol,2008

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Individual Contributions of Cardiac Ion Channels on Atrial Repolarization and Reentrant Waves: A Multiscale In-Silico Study;Journal of Cardiovascular Development and Disease;2022-01-14

2. Mechanisms, Diagnosis, and Therapy of Cardiac Arrhythmia;Practical Cardiology;2022

3. Cardioversion;Sex and Cardiac Electrophysiology;2020

4. QT as a predictor of recurrence after atrial fibrillation ablation and the impact of amiodarone: results from the placebo-controlled AMIO-CAT trial;EP Europace;2019-03-06

5. Pathway for the Management of Atrial Fibrillation and Atrial Flutter;Critical Pathways in Cardiology: A Journal of Evidence-Based Medicine;2017-06